Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Talis Biomedical Corp (NASDAQ: TLIS) was $4.38 for the day, up 5.29% from the previous closing price of $4.16. In other words, the price has increased by $5.29 from its previous closing price. On the day, 51017.0 shares were traded. TLIS stock price reached its highest trading level at $4.4837 during the session, while it also had its lowest trading level at $4.0.
Ratios:
Our analysis of TLIS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 7.76 and its Current Ratio is at 7.76. In the meantime, Its Debt-to-Equity ratio is 0.39 whereas as Long-Term Debt/Eq ratio is at 0.33.
On September 27, 2021, JP Morgan Downgraded its rating to Underweight which previously was Neutral and also lowered its target price recommendation from $10 to $7.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 26 ’24 when Leonard Braden Michael bought 13,167 shares for $3.90 per share. The transaction valued at 51,322 led to the insider holds 216,736 shares of the business.
Leonard Braden Michael bought 1,215 shares of TLIS for $4,815 on Aug 28 ’24. The 10% Owner now owns 217,951 shares after completing the transaction at $3.96 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TLIS now has a Market Capitalization of 7983952 and an Enterprise Value of -33080048. For the stock, the TTM Price-to-Sale (P/S) ratio is 462.67 while its Price-to-Book (P/B) ratio in mrq is 2.85. Its current Enterprise Value per Revenue stands at -81.079 whereas that against EBITDA is 0.726.
Stock Price History:
Over the past 52 weeks, TLIS has reached a high of $9.60, while it has fallen to a 52-week low of $3.42. The 50-Day Moving Average of the stock is -38.47%, while the 200-Day Moving Average is calculated to be -45.51%.
Shares Statistics:
TLIS traded an average of 19.26K shares per day over the past three months and 31420 shares per day over the past ten days. A total of 1.82M shares are outstanding, with a floating share count of 1.67M. Insiders hold about 94.73% of the company’s shares, while institutions hold 3.04% stake in the company. Shares short for TLIS as of 1723680000 were 17959 with a Short Ratio of 0.93, compared to 1721001600 on 13997. Therefore, it implies a Short% of Shares Outstanding of 17959 and a Short% of Float of 1.54.
